Liu, L., Li, W., & Kirschfink, M. (2012). Sublytic complement protects prostate cancer cells from tumour necrosis factor‐α‐induced cell death. Clinical & experimental immunology, 169(2), . https://doi.org/10.1111/j.1365-2249.2012.04596.x
Chicago Style (17th ed.) CitationLiu, Li, Wenhan Li, and Michael Kirschfink. "Sublytic Complement Protects Prostate Cancer Cells from Tumour Necrosis Factor‐α‐induced Cell Death." Clinical & Experimental Immunology 169, no. 2 (2012). https://doi.org/10.1111/j.1365-2249.2012.04596.x.
MLA (9th ed.) CitationLiu, Li, et al. "Sublytic Complement Protects Prostate Cancer Cells from Tumour Necrosis Factor‐α‐induced Cell Death." Clinical & Experimental Immunology, vol. 169, no. 2, 2012, https://doi.org/10.1111/j.1365-2249.2012.04596.x.
Warning: These citations may not always be 100% accurate.